Physician

Zhe Liang, MD

According to 2025 Medicare claims, Zhe Liang, MD (NPI: 1417478660) practices rheumatology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is ORTHOMIDWEST, PLLC (NPI: 1730136474; TIN: 83-4257679) and primary practice location at 61114-4937. Liang is affiliated with the OSF Healthcare System (ACO ID: A3289), participating under the MSSP model.

Liang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 718 traditional Medicare patients, billed 170,186 HCPCS/CPT codes, and received $1,627,354 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,072 prescription claims across 760 beneficiaries totaling $2,805,992 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 5 records totaling $95. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,905 to $2,805,992. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$814K$1.6M2022 Medicare payment: $289,791 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,107,931 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,627,354 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202221122,065$289,791
202359896,545$1,107,931
2024718170,186$1,627,354

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.8M2017 Drug cost: $1,905 (USD; Tot_Drug_Cst)2018 Drug cost: $15,528 (USD; Tot_Drug_Cst)2019 Drug cost: $501 (USD; Tot_Drug_Cst)2020 Drug cost: $69,578 (USD; Tot_Drug_Cst)2021 Drug cost: $349,158 (USD; Tot_Drug_Cst)2022 Drug cost: $689,004 (USD; Tot_Drug_Cst)2023 Drug cost: $1,508,636 (USD; Tot_Drug_Cst)2024 Drug cost: $2,805,992 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171541$1,905
20183390$15,528
20191235$501
202034122$69,578
202147390$349,158
2022228833$689,004
20235632,505$1,508,636
20247604,072$2,805,992

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more120120$109
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more398665$85
J0897Injection, denosumab, 1 mg1118,880$20
96372Injection of drug or substance under skin or into muscle139272$11
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg1521,199$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab992,772$674,482
RinvoqUpadacitinib651,950$412,971
Enbrel SureclickEtanercept531,484$392,521
Orencia ClickjectAbatacept26728$147,812
Actemra ActpenTocilizumab33926$147,044

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$95ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Zhe Liang, MD?

Tedicare shows public-source Medicare data for Zhe Liang, MD (NPI 1417478660), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zhe Liang, MD have ACO affiliation data?

Zhe Liang, MD is shown with ACO affiliation data for OSF Healthcare System (MSSP, ACO ID A3289).

What billing organization is linked to Zhe Liang, MD?

Zhe Liang, MD is linked to ORTHOMIDWEST, PLLC (billing NPI 1730136474) in the available physician profile data.

Does Zhe Liang, MD have Open Payments data?

Zhe Liang, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.